HIGHLIGHTS
- who: Xiaomeng Jin from the Shandong University, China have published the article: Prospects for NK-based immunotherapy of chronic HBV infection, in the Journal: (JOURNAL)
- future: Future studies should on one hand focus on technical improvements in the design for potent precise and persistent NK -based therapies and on the other hand keep on unveiling the complex interactions between HBV and NK cells. It would be interesting for future studies to determine the benefits of CXCR5 -overexpressing adoptively transferred NK cells for treating CHB.
SUMMARY
CD8+ T_cells are the crucial cellular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.